Table of Contents
• Testicular cancer overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Testicular cancer Market
• Global Epidemiology of Testicular cancer Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Testicular cancer Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Testicular cancer (2013-2023)
• Table 7: Testicular cancer Global Market (USD Millions), (2013-2015)
• Table 8: Testicular cancer Global Market (USD Millions), (2016-2023)
• Table 9: Testicular cancer US Market (USD Millions), (2013-2015)
• Table 10: Testicular cancer US Market (USD Millions), (2016-2023)
• Table 11: Testicular cancer Germany Market (USD Millions), (2013-2015)
• Table 12: Testicular cancer Germany Market (USD Millions), (2016-2023)
• Table 13: Testicular cancer United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Testicular cancer United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Testicular cancer France Market (USD Millions), (2013-2015)
• Table 16: Testicular cancer France Market (USD Millions), (2016-2023)
• Table 17: Testicular cancer Italy Market (USD Millions), (2013-2015)
• Table 18: Testicular cancer Italy Market (USD Millions), (2016-2023)
• Table 19: Testicular cancer Spain Market (USD Millions), (2013-2015)
• Table 20: Testicular cancer Spain Market (USD Millions), (2016-2023)
• Table 21: Testicular cancer Japan Market (USD Millions), (2013-2015)
• Table 22: Testicular cancer Japan Market (USD Millions), (2016-2023)
• Table 23: Testicular cancer ROW Market (USD Millions), (2013-2015)
• Table 24: Testicular cancer ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Testicular cancer Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Testicular cancer (2013-2023)
• Figure 3: Testicular cancer Global Market (USD Millions), (2013-2015)
• Figure 4: Testicular cancer Global Market (USD Millions), (2016-2023)
• Figure 5: Testicular cancer US Market (USD Millions), (2013-2015)
• Figure 6: Testicular cancer US Market (USD Millions), (2016-2023)
• Figure 7: Testicular cancer Germany Market (USD Millions), (2013-2015)
• Figure 8: Testicular cancer Germany Market (USD Millions), (2016-2023)
• Figure 9: Testicular cancer United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Testicular cancer United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Testicular cancer France Market (USD Millions), (2013-2015)
• Figure 12: Testicular cancer France Market (USD Millions), (2016-2023)
• Figure 13: Testicular cancer Italy Market (USD Millions), (2013-2015)
• Figure 14: Testicular cancer Italy Market (USD Millions), (2016-2023)
• Figure 15: Testicular cancer Spain Market (USD Millions), (2013-2015)
• Figure 16: Testicular cancer Spain Market (USD Millions), (2016-2023)
• Figure 17: Testicular cancer Japan Market (USD Millions), (2013-2015)
• Figure 18: Testicular cancer Japan Market (USD Millions), (2015-2023)
• Figure 19: Testicular cancer ROW Market (USD Millions), (2013-2015)
• Figure 20: Testicular cancer ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Merck & Co. Inc.
• Bristol-Myers Squibb Company
• Bayer AG
• ZIOPHARM Oncology Inc.
• Sanofi
• Pfizer Inc.
• AbbVie Inc.
• A. Menarini Industrie Farmaceutiche Riunite Srl
• Amgen Inc.
• Actinium Pharmaceuticals Inc.
【レポートのキーワード】
精巣がん
【免責事項】
https://www.marketreport.jp/reports-disclaimer